1. |
Mao Y, Yang D, He J, et al. Epidemiology of lung cancer. Surg Oncol Clin N Am, 2016, 25(3): 439-445.
|
2. |
Jones GS, Baldwin DR. Recent advances in the management of lung cancer. Clin Med (Lond), 2018, 18(Suppl 2): s41-s46.
|
3. |
Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature, 2018, 553(7689): 446-454.
|
4. |
Patel SA, Weiss J. Advances in the treatment of non-small cell lung cancer: Immunotherapy. Clin Chest Med, 2020, 41(2): 237-247.
|
5. |
Eun K, Ham SW, Kim H. Cancer stem cell heterogeneity: Origin and new perspectives on CSC targeting. BMB Rep, 2017, 50(3): 117-125.
|
6. |
Vlashi E, Pajonk F. Cancer stem cells, cancer cell plasticity and radiation therapy. Semin Cancer Biol, 2015, 31: 28-35.
|
7. |
Beck B, Blanpain C. Unravelling cancer stem cell potential. Nat Rev Cancer, 2013, 13(10): 727-738.
|
8. |
Perez-Cornago A, Travis RC, Appleby PN, et al. Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer, 2017, 141(2): 287-297.
|
9. |
Raza W, Luqman S, Meena A. Prospects of tangeretin as a modulator of cancer targets/pathways. Pharmacol Res, 2020, 161: 105202.
|
10. |
Gul HF, Ilhan N, Ilhan N, et al. The combined effect of pomegranate extract and tangeretin on the DMBA-induced breast cancer model. J Nutr Biochem, 2021, 89: 108566.
|
11. |
Bao H, Zheng N, Li Z, et al. Synergistic effect of tangeretin and atorvastatin for colon cancer combination therapy: Targeted delivery of these dual drugs using RGD peptide decorated nanocarriers. Drug Des Devel Ther, 2020, 14: 3057-3068.
|
12. |
Chen KH, Weng MS, Lin JK. Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. Biochem Pharmacol, 2007, 73(2): 215-227.
|
13. |
Charoensinphon N, Qiu P, Dong P, et al. 5-demethyltangeretin inhibits human nonsmall cell lung cancer cell growth by inducing G2/M cell cycle arrest and apoptosis. Mol Nutr Food Res, 2013, 57(12): 2103-2111.
|
14. |
Li YR, Li S, Ho CT, et al. Tangeretin derivative, 5-acetyloxy-6, 7, 8, 4’-tetramethoxyflavone induces G2/M arrest, apoptosis and autophagy in human non-small cell lung cancer cells in vitro and in vivo. Cancer Biol Ther, 2016, 17(1): 48-64.
|
15. |
Roshini A, Jagadeesan S, Arivazhagan L, et al. pH-sensitive tangeretin-ZnO quantum dots exert apoptotic and anti-metastatic effects in metastatic lung cancer cell line. Mater Sci Eng C Mater Biol Appl, 2018, 92: 477-488.
|
16. |
Zhu WB, Xiao N, Liu XJ. Dietary flavonoid tangeretin induces reprogramming of epithelial to mesenchymal transition in prostate cancer cells by targeting the PI3K/Akt/mTOR signaling pathway. Oncol Lett, 2018, 15(1): 433-440.
|
17. |
Hermawan A, Putri H, Hanif N, et al. Integrative bioinformatics study of tangeretin potential targets for preventing metastatic breast cancer. Evid Based Complement Alternat Med, 2021, 2021: 2234554.
|
18. |
Mdkhana B, Zaher DM, Abdin SM, et al. Tangeretin boosts the anticancer activity of metformin in breast cancer cells via curbing the energy production. Phytomedicine, 2021, 83: 153470.
|
19. |
Fan S, Xu H, Liu H, et al. Inhibition of cancer cell growth by Tangeretin flavone in drug-resistant MDA-MB-231 human breast carcinoma cells is facilitated via targeting cell apoptosis, cell cycle phase distribution, cell invasion and activation of numerous Caspases. J BUON, 2019, 24(4): 1532-1537.
|
20. |
Pan G, Liu Y, Shang L, et al. EMT-associated microRNAs and their roles in cancer stemness and drug resistance. Cancer Commun (Lond), 2021, 41(3): 199-217.
|
21. |
Walcher L, Kistenmacher AK, Suo H, et al. Cancer stem cells-origins and biomarkers: Perspectives for targeted personalized therapies. Front Immunol, 2020, 11: 1280.
|
22. |
Heng WS, Gosens R, Kruyt FAE. Lung cancer stem cells: Origin, features, maintenance mechanisms and therapeutic targeting. Biochem Pharmacol, 2019, 160: 121-133.
|
23. |
Pereira CV, Duarte M, Silva P, et al. Polymethoxylated flavones target cancer stemness and improve the antiproliferative effect of 5-fluorouracil in a 3D cell model of colorectal cancer. Nutrients, 2019, 11(2): 326.
|
24. |
Yang L, Shi P, Zhao G, et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther, 2020, 5(1): 8.
|
25. |
Dubrovska A, Kim S, Salamone RJ, et al. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci U S A, 2009, 106(1): 268-273.
|
26. |
Huang EH, Hynes MJ, Zhang T, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res, 2009, 69(8): 3382-3389.
|